Genmab — Juni 2019
-
So Usmani will use RVd lite only for high risk pts. According to Lonial they are 15-20% of ND. http://www.bloodjournal.org/content/126/13/1536?sso-checked=true
-
not sure if i posted this the other week on patient age subgroup analysis of the phase 3 CASTOR and POLLUX studies. https://www.ncbi.nlm.nih.gov/pubmed/31221782
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind